Prostate cancer is one of the common cancers among men – about 1.5-2% of all cancers (its incidence increases with age). In men over 90 years of age, microcarcinomas or larger carcinomas of the prostate gland are found in more than 80% of cases. Tumor development begins near the capsule and more often in the posterior part of the prostate, which delays symptoms and early diagnosis, since the urethra is not directly compressed. Clinic Subjective complaints are related to disturbances in the urination process (micturition disturbances). Objectively, during prostatic flushing, an enlarged and thickened prostate gland is found. Ultrasound shows changes in the gland mainly in the posterior and posterior parts. NEWS_MORE_BOX The most important laboratory sign that precedes clinical symptoms is an increase in prostate-specific antigen (PSA), which is why this test is of utmost importance for the early diagnosis of carcinoma and has been introduced as a screening test in many countries. Prostate-specific antigen is produced by the epithelial cells of the ductal and acinar epithelium. Its values ​​in the serum depend on the age, but usually above 4.5 ngml refer to a consultation with a specialist. Treatment The first method of treating prostate cancer is active surveillance. With it, the cancer is not treated, but only monitored to see if it grows and develops. This is because some of its forms develop very slowly and allow treatment to be delayed. Radiation therapy is one treatment option. It is complex therapy. After clarifying the type, malignancy and stage of the disease, a decision is made by specialist doctors – urologists, oncologists and radiation therapists about the further methods of treatment. Surgical intervention involves complete removal of the prostate. This method gives very good results at an early stage, when the process has not metastasized. In this type of surgery, the prostate, seminal vesicles, and nearby lymph nodes are removed.